Sequential Sub-passage Decreases the Differentiation Potential of Canine Adipose-derived Mesenchymal Stem Cells
Overview
Authors
Affiliations
Adipose-derived mesenchymal stem cells (AD-MSCs) are abundant in adipose tissue from animals of all ages, are easily isolated, can differentiate into multi-lineage cells, and have a clinical application. This promising potential may only be achieved if the cells are expanding in a large number while maintaining their stemness in sequential passages. In this study, canine AD-MSCs (cAD-MSCs) were individually isolated from five dogs and subjected to proliferative culture with seven sub-passages. The cells at each sub-passage were characterized for properties associated with multipotent MSCs such as proliferation kinetics, expression of MSCs-specific surface markers, expression of molecules associated with self-renewal and differentiation capabilities into mesodermal lineage cells. Proliferation of the cells plateaued at passage 5 by cumulative population doubling level, while cell doubling time gradually increased with passage. MSCs surface markers (CD44, CD90, and CD105) and molecules (Oct 3/4, Sox-2, Nanog and HMGA2) associated with self-renewal were all expressed in the cells between passages 1 to 6 by RT-PCR. In addition, the cells at passage 1, 3 or 6 underwent adipogenic and chondrogenic differentiation under specific induction conditions. However, the level of adipogenic and chondrogenic differentiation was negatively correlated with the number of sub-passage. The present study suggests that sequential sub-passages affect multipotent properties of cAD-MSCs, which should be considered in their therapeutic application in regenerative medicine.
Jeung S, An J, Kim S, Youn H Animals (Basel). 2024; 14(14).
PMID: 39061596 PMC: 11273526. DOI: 10.3390/ani14142134.
Clinical applications of adipose-derived stromal vascular fraction in veterinary practice.
Sharun K, Jambagi K, Kumar R, Gugjoo M, Pawde A, Tuli H Vet Q. 2022; 42(1):151-166.
PMID: 35841195 PMC: 9364732. DOI: 10.1080/01652176.2022.2102688.
Chen Y, Xu Y, Dai G, Shi Q, Duan C Stem Cells Int. 2022; 2022:1309684.
PMID: 35607399 PMC: 9124132. DOI: 10.1155/2022/1309684.
Di Bella S, Cannella V, Mira F, Di Marco P, Lastra A, Gucciardi F Animals (Basel). 2021; 11(6).
PMID: 34208255 PMC: 8230844. DOI: 10.3390/ani11061755.
Satani N, Zhang X, Giridhar K, Wewior N, Cai C, Aronowski J Front Pharmacol. 2021; 12:589418.
PMID: 33959001 PMC: 8093790. DOI: 10.3389/fphar.2021.589418.